These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensin-converting enzyme inhibitors in spontaneously hypertensive rats. Sugimoto K, Fujimura A. Jpn J Pharmacol; 1998 Apr; 76(4):431-4. PubMed ID: 9623722 [Abstract] [Full Text] [Related]
13. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade. Hulthén UL, Cao Z, Rumble JR, Cooper ME, Johnston CI. Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346 [Abstract] [Full Text] [Related]
14. Angiotensin-converting enzyme inhibition in adult hypertensive rats: a stereological study of renal filtration surface area. Dunstan HJ, Briscoe TA, Bertram JF, Johnston CI, Black MJ. Clin Exp Pharmacol Physiol; 2003 Sep; 30(1-2):72-6. PubMed ID: 12542457 [Abstract] [Full Text] [Related]
17. Renoprotective effects of omapatrilat are mediated partially by bradykinin. Zhou X, Ono H, Ono Y, Frohlich ED. Am J Nephrol; 2003 Sep; 23(4):214-21. PubMed ID: 12789027 [Abstract] [Full Text] [Related]
18. Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats. Teräväinen TL, Mervaala EM, Pörsti I, Laakso J, Vapaatalo H, Karppanen H. Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):311-21. PubMed ID: 9379779 [Abstract] [Full Text] [Related]
19. Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats. Wahlander H, Sohtell M, Wickman A, Nilsson A, Friberg P. J Cardiovasc Pharmacol; 1996 Mar; 27(3):327-34. PubMed ID: 8907793 [Abstract] [Full Text] [Related]